Claude Discovers CRISPR-Like Enzyme System
Claude analyzed 210 million tokens in 21 hours to flag a bacteriophage DNA system that Anthropic says may be programmable, though its function remains unknown.
- On Wednesday, September 23, 2026, Anthropic announced that its Claude AI model autonomously identified a novel enzyme system in bacteriophage DNA called array-associated reverse transcriptases after 21 hours of searching through biological data.
- The ART system features a long array of repeating DNA sequences reminiscent of CRISPR, though Anthropic emphasizes the finding is preliminary and its precise function remains unproven.
- Researchers at Anthropic's San Francisco Bay Area laboratory subsequently performed follow-up experiments confirming the DNA array produces distinct short RNAs, validating the AI's identification in a physical setting.
- Anthropic CEO Dario Amodei cited the discovery in remarks to the UN Security Council, suggesting it 'may constitute a new gene editing mechanism' with potential gene therapy applications.
- Independent microbiologists, however, caution that ART lacks proven therapeutic utility, noting the system's significance requires further peer-reviewed research and reproducibility testing before any claims can be validated.
149 Articles
149 Articles
Anthropic Says Its A.I. Discovered a New Enzyme System That Resembles the Revolutionary Gene-Editing Tool CRISPR
Experts at the company don't know what the newfound system does, so its potential utility in biology—if any—remains unclear. But the work marks a major advancement because the A.I. made this discovery mostly on its own
Anthropic's Claude Spots Unknown Enzyme in Viral DNA That Echoes CRISPR
Anthropic's Claude agents scanned vast DNA databases and flagged a previously unknown enzyme system in bacteriophages featuring CRISPR-like repeats. Called ART, the discovery involved minimal human direction during analysis yet leaves its exact function unknown. Scientists call for more study before declaring any breakthrough.
Fox News AI Newsletter: Tech company says scientific discovery could change medicine - NEW YORK TIMES POST
Anthropic CEO Dario Amodei attends a working lunch with G7 leaders, partner nations and global technology executives focused on innovation and artificial intelligence during the G7 Summit on June 17, 2026, in Évian-les-Bains, France. (Anna Moneymaker/Getty Images) NEWYou can now listen to Fox News articles! Welcome to Fox News’ Artificial Intelligence newsletter with the latest [...]
Coverage Details
Bias Distribution
- 45% of the sources lean Right
![[your]NEWS](/_next/image?url=https%3A%2F%2Fgroundnews.b-cdn.net%2Finterests%2Ffb6dc495f74049f513563c33352175eaa0ecd509.jpg%3Fwidth%3D60&w=128&q=75)
Factuality
To view factuality data please Upgrade to Premium
